Super Achiever Club
Reviewed
Verified by SAC team
+20
XP on completion
Solaray Tongkat Ali 400 mg — bottle in the SAC penthouse scene
Best Store-Brand Backup
Solaray · 400 mg root extract · 30-yr US brand · 60 caps

Solaray Tongkat Ali 400 mg Review

7.2/10SAC Product Score™

Solaray has been on US health-food store shelves since 1973 — longer than most readers of this article have been alive. The brand was acquired by Nutraceutical Corp in 1993, expanded through Sprouts, Whole Foods, and Vitamin Shoppe distribution, and built one of the deepest brick-and-mortar presences in the natural-products supplement industry. Their Tongkat Ali 400 mg bottle is a clean single-ingredient extract sitting at the upper end of the published trial gross-weight range. What you're buying isn't a category-leading formula — it's brand recognition + retail availability + a reasonable price tag, packaged together by a company that's been doing supplements longer than most of its competitors have existed. This review breaks down where Solaray's brand premium is earned, where it doesn't translate to per-cap eurycomanone visibility, and the specific buyer for whom the household-name option is the right pick.

Check on Amazon

Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.

Read the complete Tongkat Ali guide →
▸ THE SCORE

How we built the SAC Product Score™ — 7.2/10

Active-ingredient potency30%6.5/10

400 mg Tongkat root extract per cap with no declared eurycomanone percentage. Lands at the upper end of the trial gross-weight range (Henkel 2014 used exactly 400 mg/day standardised Physta). Without standardisation visibility, active eurycomanone load is estimated 4-12 mg per cap depending on the underlying lot — comparable to other generic 200:1-class extracts, below patent-tier LJ100 or Physta on a per-active-mg basis. The dose is real and trial-aligned; the visibility into what 'real' means at the molecular level isn't there.

Label trust + lab transparency25%8.5/10

Solaray's 30+ year brand history and US-stocked retail presence earn the second-highest brand-trust score in this listicle outside the NOW Foods tier. cGMP-certified manufacturing through Nutraceutical Corp's facilities, batch QC reports available on request, third-party heavy-metals testing standard. Where they fall short of NOW Foods and the patent-tier brands is per-batch published COAs — Solaray's QC documentation is request-based rather than publicly published. Above-budget-tier trust, below patent-tier trust.

Cost per active dose20%7/10

$18/month at 1 cap/day — sits between Nutricost ($15) and Double Wood generic ($28). On a gross-weight basis the price is reasonable; on a per-active-mg basis the value math is harder to verify without standardisation. The 60-cap bottle = 60-day supply at 1 cap/day = honest monthly economics. Not the cheapest, not the most expensive, lands in the value-conscious middle.

Formulation + stack15%8/10

Single-ingredient Tongkat root extract — no Tribulus filler, no Stinging Nettle adder, no BioPerine. Clean inactives (vegetable cellulose capsule, rice flour, magnesium stearate from vegetable source). This is the right formulation choice for a Tongkat-specific bottle — every milligram of the formula goes toward the active herb. Beats the multi-ingredient blends (NOW TestoJack, Herbtonics) on focus; matches the better-ranked single-ingredient bottles on cleanliness.

Real-world response10%6.5/10

Community responder rate ~55-65% — below the ~75% of patent-tier extracts. The 400 mg dose at unverified standardisation produces modest effects compared to standardised LJ100 or Physta at the same gross-weight. Lot-to-lot variability typical of generic extracts applies. Solaray's batch-to-batch consistency is good (multi-decade brand discipline), so the variability floor is lower than fly-by-night Amazon brands — but the absolute effect magnitude is still below patent-tier alternatives.

▸ SPECS

The product at a glance

Active extract
Eurycoma longifolia root extract (unspecified standardisation)
Per capsule
400 mg Tongkat root extract
Standardisation
None declared (no eurycomanone %)
Trial dose protocol
1 cap/day (matches Henkel 2014 upper-end trial dose at gross-weight level)
Bottle size
60 capsules · 60-day supply at 1 cap/day
Inactives
Vegetable cellulose, rice flour, vegetable-source magnesium stearate
Manufacturer
Solaray (Utah, US · subsidiary of Nutraceutical Corp · cGMP certified · est. 1973)
Lab transparency
Batch QC reports + heavy-metals testing on request
Retail availability
Sprouts, Whole Foods, Vitamin Shoppe, Natural Grocers + most independent health stores
Price
$18 / month at 1 cap/day
▸ TRUTH CHECK

Marketing claims vs. reality

Partial

“Pure Tongkat Ali root extract — supports healthy testosterone.”

The product is single-ingredient Tongkat root extract — the 'pure' framing is accurate. 'Supports healthy testosterone' is directionally true based on the Tongkat clinical literature (Talbott 2013, Tambi 2012, Henkel 2014) but the trials used standardised extracts; Solaray's unspecified standardisation produces an unknown active-marker dose that may or may not match the trial dose at any given batch. The claim is true in direction, uncertain in magnitude.

Verified

“400 mg per capsule — clinically-relevant dose.”

400 mg per capsule matches the Henkel 2014 trial dose at the gross-weight level. The phrase 'clinically-relevant' is technically accurate — Henkel 2014 used 400 mg/day and showed effects on free T and grip strength. The gap is that Henkel used standardised Physta, not generic extract — so the gross-weight match doesn't guarantee active-marker match. Verified at the gross-weight level, qualified at the active-marker level.

Verified

“Lab verified for purity, made in cGMP facility.”

Solaray's cGMP-certified manufacturing is verifiable through Nutraceutical Corp's published quality documentation. Heavy-metals testing is standard for the brand line, with batch QC reports available on request. The QC discipline is real and consistent — 30+ years of brand operation has built a verifiable track record. Confirmed.

Verified

“Trusted by health professionals since 1973.”

Solaray was founded in 1973 and has maintained continuous brand operation since then, including through the 1993 Nutraceutical Corp acquisition. The 'trusted by health professionals' framing is supported by the brand's broad presence in practitioner-recommended channels (independent health-food stores, naturopathic distribution). True statement, broad framing.

Verified

“Vegan, non-GMO, gluten-free.”

Verified on Solaray's product documentation — vegetable cellulose capsule, vegetable-source inactives, no wheat-derived ingredients. The certifications are consistent with Solaray's broader product line standards and the natural-products retail channel expectations.

▸ THE DEEP DIVE

What our test actually found

01The brand-trust premium is the bottle's main value proposition

Solaray Tongkat Ali at $18/month delivers a 400 mg generic-extract single-ingredient capsule with cGMP manufacturing and decent batch QC. Strip Solaray's brand off the bottle and that formulation would rank as a mid-tier budget option — call it 6.5/10 by spec sheet. The 30+ year brand history, the broad retail distribution, and the consistent QC discipline pull the score up to 7.2. That's the brand-trust premium: roughly half a point of ranking on what's otherwise a middle-of-the-pack formula. For the buyer who values 'I've seen this on shelves for years,' that's a fair trade. For the buyer who reads spec sheets without weighting brand familiarity, Solaray ranks 10th rather than higher because the spec criteria don't reward the brand-history factor as much.

02Retail availability is the underrated criterion this bottle wins on

Most Tongkat reviewers compare bottles on standardisation, dose, and price-per-cap — and they should, those criteria predict pharmacology. What gets undercounted is the practical-availability criterion. Solaray is stocked at Sprouts, Whole Foods, Vitamin Shoppe, and most independent natural-products stores in the US. The other top picks (Toniiq, Double Wood, AKARALI, Nutricost) are largely online-only. For the offline-preferring buyer — older readers, less internet-savvy buyers, anyone who prefers walking into a store and seeing the bottle in person — Solaray's retail availability is a meaningful differentiator that doesn't appear on the spec sheet. The 30-year brand history is part of WHY the retail availability exists; the two reinforce each other.

03The 400 mg dose is at the trial upper-end — that's a feature, not a flex

Solaray's 400 mg dose matches the Henkel 2014 trial protocol exactly at the gross-weight level. This is the upper end of the trial dose range (Talbott 2013 and Tambi 2012 used 200 mg/day; Henkel used 400 mg). For a one-cap-daily user, 400 mg gives more headroom than 200 mg without requiring split dosing or 2-cap protocols. This is the right dose architecture for a Tongkat product — it matches the trial-validated range without overshoot. Where the bottle loses ground is the standardisation gap: 400 mg of unspecified extract delivers an active-marker dose somewhere between Talbott and Henkel depending on lot, but you can't verify which side of that range. The dose is right; the visibility into what the dose contains is incomplete.

04Where Solaray earns 'consider' over 'skip'

The line between consider-band (7.0-8.4) and skip-band (<7.0) in our methodology is whether a buyer with the right priorities could rationally choose the product. Solaray clears this line because the brand-trust + retail-availability + clean-formulation + trial-aligned-dose combination is a coherent value proposition for the right buyer. The right buyer is someone who would buy nothing if they had to order online and wait — for that buyer, Solaray is the right bottle. The right buyer is also someone whose decision criterion includes 'a brand I recognise' — for that buyer, Solaray clears the trust threshold the way Nutricost (newer, online-native brand) might not. The consider-band score reflects this defensibility, not category leadership.

05Where Solaray loses to the higher-ranked options

Toniiq UHP (#1, 9.2) wins on per-cap eurycomanone visibility and standardisation. Double Wood LJ100 (#2, 9.0) wins on patent-licensed trial-extract specificity. Double Wood generic (#3, 8.6) wins on public per-batch COAs. AKARALI Physta (#7, 8.5) wins on the alternate clinical-trial patent extract. Nutricost (#5, 7.9) wins on cost-per-cap at the same product class. NOW TestoJack 300 (#6, 7.8) wins on retail-channel brand recognition with stronger QC documentation. Solaray's brand-history advantage is real but doesn't beat any of the spec-sheet criteria that the higher-ranked picks excel on. The 10th-place ranking is honest — Solaray is solid mid-tier, not category-leading, and the consider-band score reflects that.

▸ THE TRADE-OFFS

Pros & cons, no sugar-coating

Pros
  • 30+ year US brand history — among the longest continuous track records in the supplement industry
  • Broad retail distribution — Sprouts, Whole Foods, Vitamin Shoppe, most independent health stores
  • 400 mg cap lands at the upper end of the trial gross-weight dose range (Henkel 2014)
  • Clean single-ingredient formulation — no Tribulus filler, no BioPerine adder, no blend dilution
  • $18/month is a reasonable mid-tier price between Nutricost ($15) and Double Wood generic ($28)
Cons
  • No declared eurycomanone percentage on the label
  • Per-batch COAs are request-based rather than publicly published
  • Lower per-cap active-marker load than patent-tier LJ100, Physta, or Toniiq UHP
  • Community response rate ~10% below patent-tier extracts at similar gross-weight dose
  • Brand-trust premium doesn't translate to category-leading spec criteria
▸ THE BOTTOM LINE

Solid mid-tier — the right pick for the brand-familiarity buyer.

Solaray Tongkat Ali 400 mg is the right bottle for one specific reader segment: the buyer who values brand familiarity and brick-and-mortar availability over per-batch lab documentation. Solaray's 30+ year US brand history, broad health-store distribution, and consistent cGMP manufacturing are all real value-adds that the online-native budget brands (Nutricost, Toniiq) can't match. For the buyer who'd rather walk into a Sprouts or Whole Foods and grab a bottle they recognise than navigate Amazon listings, Solaray is the cleanest answer in this category. The $18/month price is reasonable for what the bottle delivers — single-ingredient Tongkat extract at the trial-window upper-end dose from a verifiable manufacturer. Where Solaray loses ground is the spec-sheet criteria. No declared eurycomanone percentage. No publicly published per-batch COAs. No patent-licensed clinical-trial extract. The higher-ranked picks on this listicle (Toniiq UHP, Double Wood LJ100, AKARALI Physta) all win on at least one of these dimensions; Solaray competes on brand history and retail presence instead. For the buyer whose decision criterion weights spec transparency more than brand recognition, the higher-ranked bottles are the better spend. The 'consider' verdict at 7.2 reflects this trade-off honestly. Solaray isn't bad — it's a solid mid-tier choice from a credible brand at a reasonable price. It's also not category-leading on any single criterion. The right reader for this bottle is someone who would have bought Solaray on brand familiarity anyway and wants the validation that this isn't a wrong pick. For them, the answer is yes — this is a workable bottle that delivers a trial-aligned dose from a manufacturer with three decades of operational track record. For the reader optimising on per-active-mg or lab visibility, the higher-ranked picks are the better answer.

Check Solaray · 400 mg root extract · 30-yr US brand · 60 caps on Amazon
▸ ALTERNATIVES

If this doesn’t fit — try these

Toniiq Ultra Tongkat Ali 200:1

9.2/10

Maximum per-cap eurycomanone with full COA at $45/mo. The right pick for buyers who weight active-marker visibility over brand familiarity.

See it on the list →

Double Wood LJ100 Tongkat Ali

9/10

Patent-licensed clinical-trial extract at $38/mo. The right pick for trial-extract specificity rather than brand history.

See it on the list →

Double Wood Tongkat Ali 1000 mg

8.6/10

Public per-batch COAs at $28/mo. The right pick if you want documentation rather than retail recognition.

See it on the list →

Nutricost Tongkat Ali 1000 mg

7.9/10

Same generic-extract product class at $15/mo. The right pick if you don't need the Solaray brand premium and want to optimise cost.

See it on the list →
▸ RESEARCH

Sources & further reading

  1. Talbott 2013Talbott SM, Talbott JA, George A, Pugh M · 2013 · Journal of the International Society of Sports Nutrition · PMID 23705997

    Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects

    200 mg/day standardised Physta extract for 4 weeks reduced cortisol 16% and raised testosterone 37% in stressed adults vs placebo. Frames the lower-end trial dose — Solaray's 400 mg gross-weight cap sits above this dose level at unverified standardisation.

  2. Tambi 2012Tambi MI, Imran MK, Henkel RR · 2012 · Andrologia · PMID 21671978

    Standardised water-soluble extract of Eurycoma longifolia, Tongkat Ali, as testosterone booster for managing men with late-onset hypogonadism

    200 mg/day standardised Tongkat raised total + free T into the lower normal range in 90% of hypogonadal subjects. Frames the active-marker dose Solaray's 400 mg unspecified-standardisation cap is approximating without visibility into where on the trial dose-response curve any given bottle falls.

  3. Henkel 2014Henkel RR, Wang R, Bassett SH, Chen T, Liu N, Zhu Y, Tambi MI · 2014 · Phytotherapy Research · PMID 23754792

    Tongkat Ali as a potential herbal supplement for physically active male and female seniors — a pilot study

    400 mg/day standardised Tongkat for 5 weeks improved free T and grip strength in active seniors. Direct gross-weight match to Solaray's per-cap dose — the trial-aligned protocol Solaray's 1-cap-daily delivery vehicle most closely approximates.

  4. George & Henkel 2014George A, Henkel R · 2014 · Andrologia · PMID 24528634

    Phytoandrogenic properties of Eurycoma longifolia as natural alternative to testosterone replacement therapy

    Systematic review of mechanism and clinical evidence across standardised Tongkat extracts. Concludes effect sizes track active-marker dose — frames the analytical case that Solaray's standardisation gap is the main limitation despite trial-aligned gross-weight dose.

  5. Chen 2014Chen CK, Mohamad WM, Ooi FK, Ismail SB, Abdullah MR, George A · 2014 · International Journal of Preventive Medicine · PMID 25789133

    Supplementation of Eurycoma longifolia Jack extract for 6 weeks does not affect urinary testosterone:epitestosterone ratio, liver and renal functions in male recreational athletes

    Safety dataset on standardised Tongkat over 6 weeks at trial dose. Confirms Tongkat's clean hepatic/renal safety profile applies to Solaray's 400 mg dose range — the safety floor isn't a concern, only the active-marker visibility.

▸ Build your character

Stop reading. Start leveling.

One free quiz · personalized AI Coach path · 4 missions this week. Build your character, build your life.

  • AI Coach picks 4 missions tailored to your goal
  • Earn XP, build streaks, level up four chapters
  • All evidence-based — no fluff, no upsells
Start your character →Browse missions